Flagship Pioneering has more than doubled the funding it has raised since 2021 and will direct it toward building more than a dozen companies across human health, artificial intelligence and sustainability. The plan will underscore the venture capital firm’s therapeutic area-agnostic approach and cross-pollination across the three areas.
Flagship Plans To Distribute New Fund To About Two Dozen Companies
Executive Appointments Amid Biopharma-Ag Cross-Pollination
The venture capital firm announced a $3.6bn raise for Fund VIII and side funds, which it plans to invest across human health, AI and sustainability-focused companies.
